FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study

FDA reports initial 'no signal' for stroke risk with Pfizer boosters, launches concomitant flu shot study

Source: 
Endpoints
snippet: 

The FDA hasn’t detected any potential safety signals, including for stroke, in people aged 65 years and older who have received Pfizer’s bivalent Covid booster, one senior official told members of the agency’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Thursday.